Literature DB >> 2359182

Indications for urethrectomy in an era of continent urinary diversion.

A K Levinson1, D E Johnson, K I Wishnow.   

Abstract

Interest in performing a continent urinary diversion and in preserving sexual potency after radical cystectomy for transitional cell carcinoma of the bladder has emphasized the need to identify accurately those men who are at high risk for urethral recurrences. We reviewed the records of 200 men who underwent radical cystectomy between 1969 and 1976. In 76 men urethrectomy and cystectomy were combined. Of these patients 6 had known urethral tumors and the incidence of unsuspected urethral malignancy was 2.9%. A total of 124 men had initial cystectomy only and were monitored up to 16 years (mean 67 months). Of these patients 6 (4.8%) underwent subsequent urethrectomy for malignant disease 6 to 40 months (median 23.5 months) after cystoprostatectomy. This group included 1 of 69 patients (1.5%) who presented with a solitary tumor not encroaching on the bladder neck, 1 of 22 (4.5%) with either carcinoma in situ or multifocal tumors not involving the prostate and none of the 9 with tumor at the bladder neck alone, which suggests that these patients may be satisfactory candidates for continent urinary diversion and may avoid the added risk to potency associated with urethrectomy. However, urethral recurrences were found in 4 of 24 patients (17%) who presented with disease extending into the prostate, including 3 of 10 (30%) with stromal invasion. These results emphasize the importance of assessing the prostatic urethra and ducts carefully before deciding to eliminate urethrectomy.

Entities:  

Mesh:

Year:  1990        PMID: 2359182     DOI: 10.1016/s0022-5347(17)39370-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer.

Authors:  Koji Ichihara; Hiroshi Kitamura; Naoya Masumori; Fumimasa Fukuta; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-11-08       Impact factor: 3.402

2.  A plea for a uniform surveillance schedule after radical cystectomy.

Authors:  Guido Dalbagni; Bernard H Bochner; Angel Cronin; Harry W Herr; S Machele Donat
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

3.  Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival.

Authors:  Jason L Nelles; Badrinath R Konety; Christopher Saigal; Jennifer Pace; Julie Lai
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

4.  Surveillance strategies after definitive therapy of invasive bladder cancer.

Authors:  Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

5.  Incidence of urethral tumor involvement in 910 men with bladder cancer.

Authors:  M Erckert; A Stenzl; M Falk; G Bartsch
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction.

Authors:  Wassim Kassouf; Philippe E Spiess; Gordon A Brown; Ping Liu; H Barton Grossman; Colin P N Dinney; Ashish M Kamat
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

7.  Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure.

Authors:  John P Stein; Donald G Skinner
Journal:  World J Urol       Date:  2006-03-04       Impact factor: 4.226

8.  Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.

Authors:  Xinyuan Li; Wuwan Wang; Gongmin Zhu; Weiyang He; Xin Gou
Journal:  Oncotarget       Date:  2017-12-19

9.  Is frozen section analysis of the urethra at the time of radical cystectomy and orthotopic neobladder urinary diversion mandatory?

Authors:  Sanjoy Kumar Sureka; Abhishek Yadav; Sohrab Arora; Rakesh Kapoor; Anil Mandhani
Journal:  Indian J Urol       Date:  2015 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.